Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Law to Be Named Later: Bill C-34 Punts 50 Key Decisions to Cabinet and a Digital Safety Commission That Does Not Yet Exist 
Everything All At Once: Bill C-34 Combines Platform Duties, a Kids’ Social Media Ban, AI Chatbot Regulation, and a Powerful Digital Safety Commission Into a Risky “Trust Us” Bet 
Yet Another Trade Battle Brewing: Why a Kids’ Social Media Ban Could Put Canada on a Collision Course With the U.S. 
Everything You Wanted to Know About a Kids’ Social Media Ban (But Were Rightly Afraid to Ask): A FAQ on Age Verification and Mandated ID for Everyone 
Bill C-22’s Clause-by-Clause Problem: The Government Includes Agencies Seeking Lawful Access Powers But Blocks the Privacy Commissioner’s Return
